Regardless of whether it's toys, cars, or high-tech gadgets, many U.S. companies have outsourced what they manufacture to ...

The Doctors Company, a medical malpractice insurer, said on Wednesday that it has entered into an agreement to take ...

With the conclusion of the China Development Forum (CDF), one of the country's major international event, China ushers in its ...

After Kenya, Ethiopia and Vietnam are the next in line for the access programme, and Novartis hopes to eventually extend it to at least 30 countries. To help guide the roll-out, Novartis is ...

and Vietnam. Since 2020, the global SMA treatment landscape has progressed, with three treatments now approved, according to Novartis. Along with Zolgensma – which made its debut in 2019 ...

Total Revenues in 2024 reached $492 million, representing a 427% increase over prior yearProduct Revenues in 2024 reached $273 million, ...

Swiss pharmaceutical giant Novartis (SIX:NOVN) is keeping a close eye on the U.S. tariff policy proposed by the Biden ...

KUALA LUMPUR, Malaysia, March 27, 2025 /PRNewswire/ -- Docquity, Southeast Asia's largest network of healthcare professionals (HCPs), and global healthcare company Novartis announce a multi-year ...

TOKYO -- Swiss pharmaceutical company Novartis has pegged its cancer-targeting radiopharmaceutical business as its next growth pillar, looking to make it "at least a $10 billion business" over the ...

Novartis is paying Kyorin $55 million upfront for exclusive global rights to develop, manufacture and commercialize KRP-M223, a preclinical mast-cell-targeting candidate for chronic spontaneous ...